Pear Therapeutics Inc - Ordinary Shares - Class A
NASDAQ:PEAR 1:30:24 PM EDT
Earnings Announcements
Pear Therapeutics Says Total Revenue For Q4 Of 2021 Was $1.3 Million
Published: 03/28/2022 20:15 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results.
Pear Therapeutics Inc - Pear's Total Revenue for Q4 of 2021 Was $1.3 Million, Compared With $34 Thousand.
Pear Therapeutics Inc - Qtrly Earnings per Share $0.13.
Pear Therapeutics Inc - Pear's Total Revenue for Q4 of 2021 Was $1.3 Million, Compared With $34 Thousand.
Pear Therapeutics Inc - Qtrly Earnings per Share $0.13.
Revenue is expected to be $4.28 Million
Adjusted EPS is expected to be -$0.25
Next Quarter Revenue Guidance is expected to be $6.26 Million
Next Quarter EPS Guidance is expected to be -$0.24
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.25
Next Quarter Revenue Guidance is expected to be $6.26 Million
Next Quarter EPS Guidance is expected to be -$0.24
More details on our Analysts Page.